Chronic Obstructive Pulmonary Disease (COPD)

23 Dec 2021

Asthma Management System, Blog, Chronic Obstructive Pulmonary Disease (COPD), Press Releases, Remote Patient Monitoring, Remote Therapeutic Monitoring (RTM), Telehealth 0 comments

Respiri enters its first 5 year Remote Patient Monitoring (RPM) Distribution/Marketing Agreement in the United States with mTelehealth, LLC

ASX ANNOUNCEMENT23 December 2021 Respiri enters its first 5 year Remote Patient Monitoring (RPM) Distribution/Marketing Agreement in the United States with mTelehealth, LLCHighlights:• Five-year, Non-Exclusive Distribution and Marketing Agreement signed with mTelehealth in the key USmarket• mTelehealth is a premier provider of RPM services based in Florida• First key distribution and marketing agreement signed in […]

23 Dec 2021

Asthma Management System, Blog, Chronic Obstructive Pulmonary Disease (COPD), Press Releases, wheezo - Digital Wheeze Monitor 0 comments

Here’s why the Respiri (ASX:RSH) share price jumped 14% today

The e-health company’s shares closed in the green today on news of a new partnership Published December 23, 4:39pm AEDT The Respiri Ltd (ASX: RSH) share price leapt 14% to 6.5 cents in early trading this morning. This came following the announcement of a distribution and marketing deal with a United States healthcare company. At the closing bell, Respiri shares had […]

23 Dec 2021

Asthma Management System, Blog, Chronic Disease, Chronic Obstructive Pulmonary Disease (COPD), Press Releases, wheezo - Digital Wheeze Monitor 0 comments

Respiri (ASX:RSH) enters US distribution deal with mTelehealth

Markets Reporter jessica.defreitas@themarketherald.com.au 23 December 2021 14:54 (AEDT) Respiri (RSH) signs a five-year non-exclusive distribution and marketing deal with US-based remote patient monitoring (RPM) and chronic care provider, mTelehealth mTelehealth will initially order US$150,000 (A$208,087) worth of wheezo devices and services but the deal is expected to generate US$1 million (A$1.4 million) in sales Respiri believes […]

Senators Capito, Klobuchar introduce legislation to enhance telehealth support for seniors during pandemic

18 Oct 2021

Blog, Chronic Disease, Chronic Obstructive Pulmonary Disease (COPD), Telehealth, Telemedicine 0 comments

Telemonitoring Reduces Some Exacerbation-Related Health Care Use in COPD

The study aimed to identify the usefulness of telemonitoring to detect and manage acute exacerbation of COPD (AECOPD). Telemonitoring can reduce emergency department (ED) visits and exacerbation-related readmissions, as well as acute exacerbation-related hospital days in chronic obstructive pulmonary disease (COPD), according to a recent analysis out of China. The results also showed improvements in mortality […]

29 Sep 2021

aTouchAway, Blog, Chronic Obstructive Pulmonary Disease (COPD), Press Releases, Remote Patient Monitoring, Remote Therapeutic Monitoring (RTM) 0 comments

Living Well With COPD Goes Digital

September 28, 2021 – All those with Chronic Obstructive Pulmonary Disease (COPD) now can have access to the RESPIPLUS™ Living Well with COPD self-care resources through the Aetonix aTouchAway® digital platform. More than 2 million Canadians aged 35 and older are living with COPD, a debilitating condition that impacts every element of life for its […]

23 Mar 2021

Asthma Management System, Blog, Chronic Disease, Chronic Obstructive Pulmonary Disease (COPD), Press Releases, wheezo - Digital Wheeze Monitor 0 comments

Respiri (ASX:RSH) receives FDA tick for Wheezo

Respiri (RSH) has received United States Food and Drug Administration (FDA) clearance for its wheezing aid, Wheezo Wheezo monitors wheezing to manage and improve asthma With the green tick from the FDA, the company can now market and sell the technology in the United States On the market this afternoon, Respiri is in the grey […]